News & Events

March 22, 2020

TransAlgae is a biotech company that has developed a breakthrough technology for oral delivery of drugs and vaccines, based on genetic engineering of algae. TransAlgae's technology makes the use of injections redundant. The technology is based on rapid and flexible pro...

November 1, 2017

TransAlgae is a member of a large European consortium that has recently been awarded an €8.3M H2020 grant from the EU’s “Plant Molecular Factory” call. 

The 4-year project called “Pharma Factory” will focus on advancing the production of pharmaceutical proteins and bio-...

September 3, 2017

When it comes to putting healthy fish on the dinner table, experts believe vaccination is the way to go.

February 1, 2017

TransAlgae was at the Animal Health Investment – Europe Our CTO, Dr. Ofra Chen presented at the forum - 22nd-23rd February, 2017
Millennium Hotel London Mayfair, UK.

Animal health investment website

December 1, 2016

The January 2017 BioNetworking Event featured Ofra Chen, Ph.D. from Israeli biotechnology company, TransAlgae. Dr. Chen presented a lecture entitled, "Algae Based Oral Vaccines - Applications for Aquaculture"
The Atlantic Technology Center, lower level theater, 176 Gre...

Please reload

Featured Posts

TransAlgae was selected to present as part of the Innovation Showcase at 2019 Aquaculture Innovation Europe. TransAlgae’s CTO, Dr. Ofra Chen gave a l...

September 10, 2019

Please reload

Recent Posts

November 1, 2017

Please reload

Main office and R&D lab

2 Pekeris St.  Weizmann Science Park, Rehovot,  7670202 Israel


  • TransAlgae
  • TransAlgae
  • White LinkedIn Icon